Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction: Use of ClearGuard HD caps in pediatric hemodialysis patients.
Nau A, Richardson T, Cardwell D, Ehrlich J, Gattineni J, Hanna M, Keswani M, Neibauer E, Nitz K, Quigley R, Rheault M, Sims R, Woo M, Warady BA. Nau A, et al. Pediatr Nephrol. 2024 May 8. doi: 10.1007/s00467-024-06393-7. Online ahead of print. Pediatr Nephrol. 2024. PMID: 38717613 No abstract available.
Patient-Reported Dry Eye Treatment and Burden of Care.
Nau CB, Nau AC, Fogt JS, Harthan JS, Shorter ES, Schornack MM. Nau CB, et al. Among authors: nau ac. Eye Contact Lens. 2024 Jun 1;50(6):259-264. doi: 10.1097/ICL.0000000000001086. Epub 2024 Apr 16. Eye Contact Lens. 2024. PMID: 38625757
Use of ClearGuard HD caps in pediatric hemodialysis patients.
Nau A, Richardson T, Cardwell D, Ehrlich J, Gattineni J, Hanna M, Keswani M, Neibauer E, Nitz K, Quigley R, Rheault M, Sims R, Woo M, Warady BA. Nau A, et al. Pediatr Nephrol. 2024 Jan 25. doi: 10.1007/s00467-023-06273-6. Online ahead of print. Pediatr Nephrol. 2024. PMID: 38267590
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.
Haddox CL, Nathenson MJ, Mazzola E, Lin JR, Baginska J, Nau A, Weirather JL, Choy E, Marino-Enriquez A, Morgan JA, Cote GM, Merriam P, Wagner AJ, Sorger PK, Santagata S, George S. Haddox CL, et al. Among authors: nau a. Clin Cancer Res. 2024 Apr 1;30(7):1281-1292. doi: 10.1158/1078-0432.CCR-23-2250. Clin Cancer Res. 2024. PMID: 38236580 Free PMC article. Clinical Trial.
Ziv-aflibercept plus pembrolizumab in patients with advanced melanoma resistant to anti-PD-1 treatment.
Baginska J, Nau A, Gomez Diaz I, Giobbie-Hurder A, Weirather J, Vergara J, Abrecht C, Hallisey M, Dennis J, Severgnini M, Huezo J, Marciello I, Rahma O, Manos M, Brohl AS, Bedard PL, Renouf DJ, Sharon E, Streicher H, Ott PA, Buchbinder EI, Hodi FS. Baginska J, et al. Among authors: nau a. Cancer Immunol Immunother. 2024 Jan 18;73(1):17. doi: 10.1007/s00262-023-03593-2. Cancer Immunol Immunother. 2024. PMID: 38236249 Free PMC article. Clinical Trial.
106 results